(PBI)

Role: EVP/Gen Counsel & Corp Sec
Signature: Elisabeth Weinberg, as attorney in fact for Freeman-Bosworth Lauren
Issuer symbol: PBI
Transactions as of: 29 Nov 2024
Net transactions value: -$163,753
Form type: 4
Filing time: 03 Dec 2024, 14:56:36 UTC
Previous filing: 22 Apr 2024
Next filing: 27 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBI	Common Stock	Options Exercise	$179,700	+30,000	+97%	$5.99	60,972	29 Nov 2024	Direct	F1
transaction	PBI	Common Stock	Sale	$243,318	-30,000	-49%	$8.11	30,972	29 Nov 2024	Direct	F1, F2
transaction	PBI	Common Stock	Sale	$100,135	-12,308	-40%	$8.14	18,664	29 Nov 2024	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBI	Stock Options (Right to buy)	Options Exercise	$0	-30,000	-50%	$0.000000	30,000	29 Nov 2024	Common Stock	30,000	$5.99	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The stock option exercises and broker-assisted sales transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 30, 2024 during the Company's open window period (the "Trading Plan").
F2	The price reported here is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.04 to $8.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3	The price reported here is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.04 to $8.24, inclusive.